T36.6X2

Clinical Causes: Intentional overdose of rifampicins as a form of self-harm Psychological conditions such as depression, suicidal ideation, or bipolar disorder leading to deliberate ingestion of excessive medication Lack of awareness about the risks associated with rifampicin overdose Attempted suicide or self-injury motivated by emotional distress Misjudgment of the severity or lethality of the medication

Key Symptoms: Gastrointestinal symptoms such as nausea, vomiting, and abdominal pain Signs of liver damage including jaundice (yellowing of skin and eyes), dark urine, and fatigue Hematological effects like anemia or abnormal blood clotting Allergic reactions which could include rash, fever, or swelling Altered mental status such as confusion or agitation in severe cases Potential kidney impairment presenting as decreased urine output or swelling In severe poisoning, symptoms may escalate to respiratory distress or coma

Diagnosis Path: Blood tests to measure rifampicin levels and assess liver and kidney function Complete blood count (CBC) to identify hematological abnormalities Liver function tests (LFTs) for hepatotoxicity Urinalysis to detect kidney involvement Electrocardiogram (ECG) if cardiac symptoms are present Psychological evaluation to understand underlying motives and mental health status

Treatment Protocols: Gastrointestinal decontamination such as activated charcoal administration if within the appropriate time window after ingestion Intravenous fluids to maintain hydration and support organ function Medications to manage specific symptoms, like antiemetics for nausea Liver support therapies if hepatotoxicity develops Monitoring of vital signs and organ functions in a hospital setting Psychiatric support and counseling to address underlying mental health issues Long-term psychological therapy to prevent future episodes of self-harm